NCCP Guidance on Inter Hospital Supply of Compounded Parenteral Systemic Anti-Cancer Therapy (SACT) as a Business Continuity Measure

This document is intended to provide guidance on the inter hospital supply of compounded parenteral SACT as a business continuity measure. It summarises the relevant legislation and professional responsibilities of pharmacists and may inform hospitals business continuity plans for compounded parenteral SACT.